KaydedilenlerDerginizi ekleyin

Dergiler / Annals of Medical Research / 2021 / Cilt: 28 - Sayı: 10

Does graves' ophthalmopathy affect anterior segment parameters?

Deniz Kilic
Baris Onder Pamuk
Fahrettin Akay
Yusuf Ziya Guven
Berkay Akmaz
Soner Guven
Sayfa
1892–1895
Yayın Tarihi
2022-10-12
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: The ASPs were not associated with significant alterations between patients with GO and controls.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aim: To evaluate whether anterior segment parameters (ASPs) differ between patients with Graves’s ophthalmopathy (GO) and healthy individuals.
📊
Temel Bulgular & Veri:Materials and Methods: In a case-control study, 62 patients with GO and 45 healthy sex- and age-matched individuals were compared for ASPs obtained from Scheimpflug camera imaging (Sirius, Florence, Italy).
💡
Sonuç & Katkı:Conclusion: The ASPs were not associated with significant alterations between patients with GO and controls.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Aim: To evaluate whether anterior segment parameters (ASPs) differ between patients with Graves’s ophthalmopathy (GO) and healthy individuals. Materials and Methods: In a case-control study, 62 patients with GO and 45 healthy sex- and age-matched individuals were compared for ASPs obtained from Scheimpflug camera imaging (Sirius, Florence, Italy). The ASPs were anterior chamber depth (ACD), anterior chamber volume (ACV), iridocorneal angle (ICA), corneal volume, corneal curvatures (K1, K2, and Kmean), and white-to-white, apical, and thinnest corneal thickness. Results: Mean white-to-white corneal distance, corneal volume, ACD, ACV, ICA, K1, K2, and Kmean were similar between patients and controls (p = 0.815, p = 0.285, p = 0.522, p = 0.102, p = 0.275, p = 0.114, p = 0.566, p = 0.137, p = 0.405, and p = 0.447, respectively). There was a negative correlation between mean Hertel measurement and mean ACD (r = - 0.284, p = 0.003), ACV (r = - 0.283, p = 0.003), and ICA (r = - 0.295, p = 0.002). Conclusion: The ASPs were not associated with significant alterations between patients with GO and controls.

🔖

Bu Makaleye Atıf Yap

Kilic, D., Pamuk, B. O., Akay, F., Guven, Y. Z., Akmaz, B., Guven, S. (2022). Does graves' ophthalmopathy affect anterior segment parameters?. Annals of Medical Research, Cilt: 28 - Sayı: 10, 1892–1895. https://ajindex.com/articles/445967

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (19)

  1. Smith TJ, Hegedus L. Graves’ Disease. N Engl J Med 2016;375:1552-65
  2. Rapoport B, Chazenbalk GD, Jaume JC, et al. The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies. Endocr Rev 1998;19:673-716
  3. Weetman AP. Graves’ Disease. N Engl J Med 2000;343:1236-48
  4. Wall JR, Lahooti H. Pathogenesis of thyroid eye disease--does autoimmunity against the TSH receptor explain all cases? Endokrynol Pol 2010;61:222-7
  5. Levy J, Puterman M, Lifshitz T, et al. Endoscopic orbital decompression for Graves’ ophthalmopathy. Isr Med Assoc J 2004;6:673-6
  6. Zhou X, Zhou D, Wang J, et al. Treatment strategies for Graves’ ophthalmopathy: a network meta-analysis. Br J Ophthalmol Published Online First: July 2019
  7. Weiler DL. Thyroid eye disease: a review. Clin Exp Optom 2017;100:20-5
  8. Rundle FF, Wilson CW. Development and course of exophthalmos and ophthalmoplegia in Graves’ disease with special reference to the effect of thyroidectomy. Clin Sci 1945;5:177-94
  9. Caliskan S, Acar M, Gurdal C. Choroidal Thickness in Patients with Graves’ Ophthalmopathy. Curr Eye Res 2017;42:484-90
  10. Bartley GB, Fatourechi V, Kadrmas EF, et al. Chronology of Graves’ ophthalmopathy in an incidence cohort. Am J Ophthalmol 1996;121:426-34
  11. Dutton JJ. Anatomic Considerations in Thyroid Eye Disease. Ophthal Plast Reconstr Surg 2018;34:7-12
  12. Fernando R, Smith TJ. Slit2 Regulates Hyaluronan & Cytokine Synthesis in Fibrocytes: Potential Relevance to Thyroid-Associated Ophthalmopathy. J Clin Endocrinol Metab 2021;106:e20-33
  13. Inoue S, Kawashima M, Arita R, et al. Investigation of Meibomian Gland Function and Dry Eye Disease in Patients with Graves’ Ophthalmopathy. J Clin Med 2020;9
  14. Wang YH, Ma J, Li H, et al. [Peripapillary and macular vessel density in eyes with different phases of thyroidassociated ophthalmopathy]. Zhonghua Yan Ke Za Zhi 2020;56:824-31
  15. Karabulut GO, Kaynak P, Altan C, et al. Corneal biomechanical properties in thyroid eye disease. Kaohsiung J Med Sci 2014;30:299-304
  16. Dolman PJ. Grading Severity and Activity in Thyroid Eye Disease. Ophthal Plast Reconstr Surg 2018;34:34- 40
  17. Dolman PJ, Rootman J. VISA Classification for Graves orbitopathy. Ophthal Plast Reconstr Surg 2006;22:319-24
  18. Savini G, Barboni P, Carbonelli M, et al. Repeatability of automatic measurements by a new Scheimpflug camera combined with Placido topography. J Cataract Refract Surg 2011;37:1809-16
  19. Yang X, Huang D, Ai S, et al. Retinal Vessel Oxygen Sa